Summary
- Current Price
- As of today, AARD price is $6.82, up +15.79% on
- Current Price All-Time High
- AARD price is currently -65.17% below its historical high of $19.58 set on
- Market Cap
- AARD current market cap is $149M, down -29.29% year-over-year
- Revenue
- AARD current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AARD is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aardvark Therapeutics, Inc. |
| Ticker | NASDAQ: AARD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aardvarktherapeutics.com |
| Employees | 26 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $6.82 | ||
| Price, 1D Change | +15.79% | |
| $149M | ||
| - | ||
| - | ||
| 3.21 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.64 | ||
| EPS, 1Y Change | -178.21% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.64 | ||
| EPS Estimate | -$3.06 | N/A |
| EPS Est. Change | -15.85% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $6.82 | ||
| Price Target | $6.50 | - |
| Price Tgt. Change | -4.69% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.58 | -$0.95 | -63.60% | |
| -$2.94 | -$2.64 | +10.21% | |
| -$3.06 | N/A | -15.85% | |
| -$2.78 | N/A | -5.39% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -29.91% | ||
| - | ||
| -29.29% | ||
| - | ||
| 0.00% | ||
| 0.00% | ||
| -178.21% | ||
| -316.19% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $6.82 | ||
| $8.17 | ||
| $5.89 | ||
| $7.45 | ||
| $6.16 | ||
| $0.13 | ||
| 3.21 | ||
| $0.86 | ||
| 52.75 | ||
| 141.04% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.64 | ||
| -$36.00K | ||
| - | ||
| -$62.73M | ||
| - | ||
| -$57.59M | ||
| - | ||
| -$62.69M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 10.61 | ||
| 10.61 | ||
| - | ||
| - | ||
| 6.38 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 2.00 | ||
| -1.03 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $106.63M | ||
| $110.03M | ||
| $117.18M | ||
| $111.89M | ||
| $10.55M | ||
| $10.55M | ||
| $441.00K | ||
| $441.00K | ||
| $2.07M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $57.59M | ||
| $62.69M | ||
| $36.00K | ||
| $0.00 | ||
| $36.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$54.17M | ||
| -$49.67M | ||
| $89.25M | ||
| $95.00K | ||
| -$54.27M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Morgan Stanley | → | |
| BTIG | → | |
| B. Riley Securities | → | |
| BTIG | → | |
| Stifel | → | |
| RBC Capital | → | |
| Oppenheimer | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with AARD
FAQ
- What is the ticker symbol for Aardvark Therapeutics, Inc.?
- The ticker symbol for Aardvark Therapeutics, Inc. is NASDAQ:AARD
- Does Aardvark Therapeutics, Inc. pay dividends?
- No, Aardvark Therapeutics, Inc. does not pay dividends
- What sector is Aardvark Therapeutics, Inc. in?
- Aardvark Therapeutics, Inc. is in the Healthcare sector
- What industry is Aardvark Therapeutics, Inc. in?
- Aardvark Therapeutics, Inc. is in the Biotechnology industry
- What country is Aardvark Therapeutics, Inc. based in?
- Aardvark Therapeutics, Inc. is headquartered in United States
- When did Aardvark Therapeutics, Inc. go public?
- Aardvark Therapeutics, Inc. initial public offering (IPO) was on February 13, 2025
- Is Aardvark Therapeutics, Inc. in the S&P 500?
- No, Aardvark Therapeutics, Inc. is not included in the S&P 500 index
- Is Aardvark Therapeutics, Inc. in the NASDAQ 100?
- No, Aardvark Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Aardvark Therapeutics, Inc. in the Dow Jones?
- No, Aardvark Therapeutics, Inc. is not included in the Dow Jones index
- When was Aardvark Therapeutics, Inc. last earnings report?
- Aardvark Therapeutics, Inc.'s most recent earnings report was on August 11, 2026
- When does Aardvark Therapeutics, Inc. report earnings?
- The next expected earnings date for Aardvark Therapeutics, Inc. is November 12, 2026
Data Sources & References
- AARD Official Website aardvarktherapeutics.com
- AARD Profile on Yahoo Finance finance.yahoo.com/quote/AARD
- AARD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aard